Persium Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$812K Buy
9,366
+538
+6% +$51.5K 0.64% 28
2025
Q4
$848K Buy
8,828
+395
+5% +$38.4K 0.61% 23
2025
Q3
$803K Buy
8,433
+487
+6% +$44.8K 0.6% 25
2025
Q2
$693K Buy
7,946
+343
+5% +$29.1K 0.57% 26
2025
Q1
$683K Buy
7,603
+337
+5% +$30.2K 0.65% 18
2024
Q4
$580K Buy
+7,266
New +$629K 0.57% 30

Other funds holding MDT

Persium Advisors's MDT Position: Q1 2026 in Review

Persium Advisors increased its Medtronic (MDT) stake by 6.1% in Q1 2026, buying an estimated $51.5K and bringing the position to 9,366 shares worth $812K. The position accounts for 0.64% of the portfolio, ranked #28.

Persium Advisors first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. The position peaked at $848K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Persium Advisors held 9,366 shares of Medtronic worth $812K as of Q1 2026.
  • Persium Advisors bought 538 Medtronic shares in Q1 2026, an estimated $51.5K.
  • Medtronic made up 0.64% of Persium Advisors's portfolio in Q1 2026, its #28 holding.
  • Persium Advisors first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • Persium Advisors's Medtronic position peaked at $848K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Persium Advisors's 13F filing for Q1 2026, filed 1 May 2026.